Jason Tregellas
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 35 | 2026 | 537 | 9.520 |
Why?
| | Brain | 51 | 2026 | 2991 | 6.310 |
Why?
| | Magnetic Resonance Imaging | 69 | 2026 | 3926 | 5.280 |
Why?
| | Nerve Net | 20 | 2026 | 286 | 4.700 |
Why?
| | Brain Mapping | 39 | 2023 | 541 | 4.410 |
Why?
| | Connectome | 7 | 2026 | 100 | 3.170 |
Why?
| | Nicotinic Agonists | 9 | 2019 | 140 | 2.930 |
Why?
| | Sensory Gating | 6 | 2024 | 45 | 2.820 |
Why?
| | Hippocampus | 14 | 2026 | 989 | 2.690 |
Why?
| | Nicotine | 10 | 2017 | 337 | 2.680 |
Why?
| | Schizophrenic Psychology | 9 | 2019 | 121 | 2.390 |
Why?
| | Neural Pathways | 12 | 2024 | 319 | 2.290 |
Why?
| | Obesity | 19 | 2026 | 3131 | 2.200 |
Why?
| | Cerebral Cortex | 15 | 2020 | 485 | 1.820 |
Why?
| | Feeding Behavior | 9 | 2023 | 692 | 1.790 |
Why?
| | Energy Intake | 9 | 2019 | 507 | 1.700 |
Why?
| | Overweight | 7 | 2025 | 614 | 1.650 |
Why?
| | Image Processing, Computer-Assisted | 22 | 2019 | 778 | 1.630 |
Why?
| | Hunger | 7 | 2023 | 56 | 1.570 |
Why?
| | Antipsychotic Agents | 4 | 2024 | 185 | 1.480 |
Why?
| | Psychotic Disorders | 4 | 2024 | 188 | 1.470 |
Why?
| | Cognition | 6 | 2026 | 1292 | 1.470 |
Why?
| | Attention | 8 | 2016 | 463 | 1.400 |
Why?
| | Auditory Perception | 5 | 2014 | 107 | 1.250 |
Why?
| | Epilepsies, Partial | 2 | 2021 | 62 | 1.240 |
Why?
| | Cues | 7 | 2022 | 326 | 1.200 |
Why?
| | Food | 5 | 2022 | 149 | 1.180 |
Why?
| | Evoked Potentials, Auditory | 6 | 2015 | 187 | 1.130 |
Why?
| | Drug Resistant Epilepsy | 2 | 2021 | 145 | 1.110 |
Why?
| | Motor Activity | 3 | 2026 | 704 | 1.110 |
Why?
| | Adult | 74 | 2026 | 41087 | 1.080 |
Why?
| | Electroencephalography | 6 | 2024 | 576 | 1.070 |
Why?
| | Acoustic Stimulation | 9 | 2016 | 325 | 1.030 |
Why?
| | Appetite Regulation | 5 | 2019 | 31 | 1.010 |
Why?
| | Male | 81 | 2026 | 73396 | 1.000 |
Why?
| | Appetite | 9 | 2023 | 80 | 0.970 |
Why?
| | Bipolar Disorder | 3 | 2024 | 285 | 0.970 |
Why?
| | Visual Perception | 7 | 2013 | 184 | 0.960 |
Why?
| | Hypothalamus | 2 | 2026 | 161 | 0.950 |
Why?
| | Single-Blind Method | 9 | 2026 | 313 | 0.930 |
Why?
| | Psychomotor Performance | 6 | 2016 | 329 | 0.920 |
Why?
| | Female | 80 | 2026 | 79499 | 0.910 |
Why?
| | Reward | 7 | 2024 | 242 | 0.910 |
Why?
| | Epilepsy | 2 | 2021 | 400 | 0.900 |
Why?
| | Humans | 102 | 2026 | 146342 | 0.890 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2015 | 422 | 0.880 |
Why?
| | Executive Function | 3 | 2019 | 463 | 0.880 |
Why?
| | Sex Characteristics | 4 | 2023 | 801 | 0.860 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 5 | 2019 | 105 | 0.850 |
Why?
| | Cross-Over Studies | 10 | 2026 | 615 | 0.840 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 481 | 0.820 |
Why?
| | Prefrontal Cortex | 7 | 2025 | 339 | 0.820 |
Why?
| | Neurons | 6 | 2017 | 1668 | 0.760 |
Why?
| | Neuroimaging | 3 | 2020 | 307 | 0.750 |
Why?
| | Benzylidene Compounds | 3 | 2016 | 23 | 0.730 |
Why?
| | Neuropsychological Tests | 12 | 2026 | 1149 | 0.730 |
Why?
| | Cerebellum | 4 | 2013 | 225 | 0.710 |
Why?
| | Obesity, Morbid | 1 | 2026 | 287 | 0.710 |
Why?
| | Weight Gain | 3 | 2024 | 562 | 0.710 |
Why?
| | Headache | 1 | 2023 | 150 | 0.700 |
Why?
| | Pursuit, Smooth | 5 | 2010 | 20 | 0.690 |
Why?
| | Premature Birth | 1 | 2026 | 390 | 0.680 |
Why?
| | Eating | 4 | 2023 | 386 | 0.680 |
Why?
| | Adiposity | 1 | 2026 | 533 | 0.680 |
Why?
| | Infant, Premature | 1 | 2026 | 622 | 0.660 |
Why?
| | Satiation | 4 | 2019 | 26 | 0.640 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 337 | 0.640 |
Why?
| | Noise | 2 | 2012 | 68 | 0.620 |
Why?
| | Electrocorticography | 1 | 2020 | 20 | 0.620 |
Why?
| | Exercise | 5 | 2025 | 2213 | 0.620 |
Why?
| | Sensation Disorders | 2 | 2013 | 38 | 0.620 |
Why?
| | Cholinergic Agents | 3 | 2016 | 18 | 0.620 |
Why?
| | Neurovascular Coupling | 1 | 2019 | 10 | 0.600 |
Why?
| | Torticollis | 1 | 2019 | 21 | 0.600 |
Why?
| | Magnetoencephalography | 1 | 2020 | 161 | 0.590 |
Why?
| | Cognition Disorders | 5 | 2019 | 559 | 0.570 |
Why?
| | Middle Aged | 37 | 2026 | 36619 | 0.560 |
Why?
| | Pediatric Obesity | 1 | 2026 | 635 | 0.560 |
Why?
| | Reaction Time | 8 | 2025 | 438 | 0.550 |
Why?
| | Pyridines | 3 | 2016 | 610 | 0.540 |
Why?
| | Oxygen | 10 | 2017 | 997 | 0.530 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 312 | 0.520 |
Why?
| | Food Preferences | 2 | 2016 | 126 | 0.520 |
Why?
| | Memory, Short-Term | 1 | 2019 | 276 | 0.480 |
Why?
| | Hemodynamics | 2 | 2019 | 1114 | 0.480 |
Why?
| | Thalamus | 2 | 2009 | 134 | 0.480 |
Why?
| | Antiparkinson Agents | 1 | 2016 | 41 | 0.480 |
Why?
| | Analysis of Variance | 7 | 2017 | 1298 | 0.470 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 447 | 0.460 |
Why?
| | Repetition Priming | 1 | 2015 | 9 | 0.450 |
Why?
| | Diet, Ketogenic | 1 | 2015 | 40 | 0.440 |
Why?
| | Nutrition Policy | 1 | 2015 | 56 | 0.440 |
Why?
| | Limbic System | 2 | 2015 | 55 | 0.420 |
Why?
| | Parkinson Disease | 2 | 2023 | 614 | 0.420 |
Why?
| | Clozapine | 1 | 2014 | 20 | 0.410 |
Why?
| | Leptin | 2 | 2012 | 248 | 0.400 |
Why?
| | Young Adult | 19 | 2026 | 14330 | 0.400 |
Why?
| | Endophenotypes | 1 | 2013 | 37 | 0.390 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 75 | 0.380 |
Why?
| | Semantics | 2 | 2013 | 96 | 0.380 |
Why?
| | Fingers | 1 | 2013 | 106 | 0.380 |
Why?
| | Brain Waves | 1 | 2013 | 45 | 0.380 |
Why?
| | Frontal Lobe | 4 | 2016 | 159 | 0.370 |
Why?
| | Body Mass Index | 6 | 2023 | 2458 | 0.360 |
Why?
| | Behavior Therapy | 1 | 2015 | 291 | 0.360 |
Why?
| | Efficiency | 1 | 2012 | 102 | 0.350 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 522 | 0.340 |
Why?
| | Patient Compliance | 1 | 2015 | 589 | 0.330 |
Why?
| | Photic Stimulation | 7 | 2016 | 265 | 0.330 |
Why?
| | Dronabinol | 1 | 2014 | 251 | 0.320 |
Why?
| | Hallucinations | 1 | 2010 | 33 | 0.320 |
Why?
| | Autistic Disorder | 3 | 2009 | 216 | 0.310 |
Why?
| | Space Perception | 1 | 2010 | 82 | 0.300 |
Why?
| | Reproducibility of Results | 5 | 2024 | 3416 | 0.300 |
Why?
| | Functional Neuroimaging | 4 | 2019 | 61 | 0.300 |
Why?
| | Thinking | 2 | 2009 | 68 | 0.290 |
Why?
| | Statistics as Topic | 4 | 2017 | 279 | 0.290 |
Why?
| | Functional Laterality | 4 | 2013 | 242 | 0.290 |
Why?
| | Urbanization | 1 | 2009 | 28 | 0.280 |
Why?
| | Nutritional Status | 1 | 2011 | 346 | 0.280 |
Why?
| | Body Weight | 1 | 2012 | 968 | 0.270 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 2022 | 0.270 |
Why?
| | Longitudinal Studies | 3 | 2026 | 3017 | 0.260 |
Why?
| | Eye Movements | 2 | 2010 | 92 | 0.250 |
Why?
| | Anorexia Nervosa | 3 | 2014 | 82 | 0.250 |
Why?
| | Hyperphagia | 3 | 2019 | 37 | 0.250 |
Why?
| | Case-Control Studies | 7 | 2017 | 3647 | 0.250 |
Why?
| | Adolescent | 11 | 2026 | 22557 | 0.240 |
Why?
| | Gyrus Cinguli | 5 | 2025 | 98 | 0.240 |
Why?
| | Child | 9 | 2021 | 22693 | 0.230 |
Why?
| | Decision Making | 1 | 2013 | 993 | 0.220 |
Why?
| | Taste | 3 | 2014 | 237 | 0.220 |
Why?
| | Delay Discounting | 1 | 2025 | 29 | 0.220 |
Why?
| | Computer Graphics | 2 | 2015 | 41 | 0.210 |
Why?
| | Social Behavior | 1 | 2006 | 279 | 0.210 |
Why?
| | Diet | 3 | 2025 | 1273 | 0.200 |
Why?
| | Educational Status | 1 | 2026 | 466 | 0.200 |
Why?
| | Ocular Motility Disorders | 1 | 2004 | 42 | 0.190 |
Why?
| | Echo-Planar Imaging | 1 | 2002 | 24 | 0.190 |
Why?
| | Animals | 9 | 2019 | 38107 | 0.190 |
Why?
| | Machine Learning | 2 | 2026 | 594 | 0.180 |
Why?
| | Child Development Disorders, Pervasive | 2 | 2013 | 64 | 0.180 |
Why?
| | Gestational Age | 1 | 2026 | 990 | 0.180 |
Why?
| | Atrophy | 3 | 2023 | 199 | 0.180 |
Why?
| | Learning | 1 | 2006 | 446 | 0.170 |
Why?
| | Risk | 1 | 2024 | 920 | 0.170 |
Why?
| | Biomarkers | 4 | 2019 | 4340 | 0.170 |
Why?
| | Smoking | 2 | 2007 | 1486 | 0.160 |
Why?
| | Infant | 2 | 2026 | 10114 | 0.160 |
Why?
| | Maternal Inheritance | 1 | 2020 | 16 | 0.160 |
Why?
| | Psychometrics | 1 | 2024 | 712 | 0.160 |
Why?
| | Organ Size | 3 | 2012 | 465 | 0.160 |
Why?
| | Fasting | 4 | 2019 | 280 | 0.160 |
Why?
| | Rest | 1 | 2020 | 126 | 0.150 |
Why?
| | Exercise Therapy | 1 | 2025 | 488 | 0.150 |
Why?
| | Weight Loss | 2 | 2019 | 858 | 0.150 |
Why?
| | Neural Inhibition | 2 | 2015 | 186 | 0.150 |
Why?
| | Child Development | 1 | 2024 | 481 | 0.150 |
Why?
| | Parietal Lobe | 2 | 2013 | 62 | 0.150 |
Why?
| | Thinness | 2 | 2011 | 100 | 0.140 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2019 | 69 | 0.140 |
Why?
| | Diet, Reducing | 1 | 2019 | 90 | 0.140 |
Why?
| | Drug Users | 2 | 2016 | 43 | 0.140 |
Why?
| | Substance-Related Disorders | 3 | 2013 | 1100 | 0.130 |
Why?
| | Food Analysis | 1 | 2017 | 22 | 0.130 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 278 | 0.130 |
Why?
| | Energy Metabolism | 2 | 2014 | 930 | 0.130 |
Why?
| | Temporal Lobe | 2 | 2020 | 112 | 0.130 |
Why?
| | Gastric Bypass | 1 | 2019 | 115 | 0.130 |
Why?
| | Seizures | 1 | 2021 | 489 | 0.130 |
Why?
| | Tobacco Use Disorder | 1 | 2019 | 217 | 0.130 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 6073 | 0.120 |
Why?
| | Mice | 4 | 2015 | 18297 | 0.120 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 185 | 0.120 |
Why?
| | Levodopa | 1 | 2016 | 40 | 0.120 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 9 | 0.120 |
Why?
| | Social Control, Informal | 2 | 2013 | 21 | 0.120 |
Why?
| | Child, Preschool | 3 | 2020 | 11913 | 0.120 |
Why?
| | Basal Metabolism | 1 | 2016 | 58 | 0.110 |
Why?
| | Aversive Therapy | 1 | 2015 | 3 | 0.110 |
Why?
| | Dietary Fiber | 1 | 2016 | 59 | 0.110 |
Why?
| | Lost to Follow-Up | 1 | 2015 | 19 | 0.110 |
Why?
| | Hormones | 1 | 2016 | 134 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1998 | 0.110 |
Why?
| | Mental Disorders | 1 | 2024 | 1148 | 0.110 |
Why?
| | Cerebrovascular Circulation | 2 | 2009 | 293 | 0.110 |
Why?
| | Ketones | 1 | 2015 | 51 | 0.110 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 406 | 0.110 |
Why?
| | Choice Behavior | 1 | 2016 | 179 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 288 | 0.110 |
Why?
| | Cohort Studies | 3 | 2020 | 6077 | 0.110 |
Why?
| | Dietary Proteins | 1 | 2016 | 135 | 0.110 |
Why?
| | Administration, Cutaneous | 1 | 2014 | 128 | 0.110 |
Why?
| | Sweetening Agents | 1 | 2014 | 57 | 0.100 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 6 | 0.100 |
Why?
| | Time Factors | 3 | 2015 | 7109 | 0.100 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 71 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2026 | 6460 | 0.100 |
Why?
| | Gamma Rhythm | 1 | 2013 | 7 | 0.100 |
Why?
| | Computer Simulation | 2 | 2019 | 1014 | 0.100 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 186 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2021 | 11821 | 0.100 |
Why?
| | Regression Analysis | 4 | 2019 | 999 | 0.100 |
Why?
| | Visual Cortex | 2 | 2005 | 84 | 0.100 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 252 | 0.100 |
Why?
| | Psycholinguistics | 1 | 2013 | 20 | 0.100 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 307 | 0.090 |
Why?
| | Aged | 4 | 2026 | 26432 | 0.090 |
Why?
| | Symptom Assessment | 1 | 2014 | 138 | 0.090 |
Why?
| | Heart Rate | 1 | 2017 | 846 | 0.090 |
Why?
| | Satiety Response | 1 | 2012 | 11 | 0.090 |
Why?
| | Drug Discovery | 1 | 2013 | 154 | 0.090 |
Why?
| | Drug Interactions | 1 | 2014 | 405 | 0.090 |
Why?
| | Models, Animal | 1 | 2014 | 387 | 0.090 |
Why?
| | Body Composition | 1 | 2016 | 689 | 0.090 |
Why?
| | Blood Glucose | 2 | 2019 | 2360 | 0.090 |
Why?
| | Conduct Disorder | 1 | 2013 | 159 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 203 | 0.090 |
Why?
| | Fornix, Brain | 1 | 2011 | 5 | 0.080 |
Why?
| | Health Behavior | 1 | 2017 | 802 | 0.080 |
Why?
| | Insulin | 2 | 2019 | 2525 | 0.080 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 47 | 0.080 |
Why?
| | Subliminal Stimulation | 1 | 2010 | 2 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5899 | 0.080 |
Why?
| | Sensation | 1 | 2011 | 56 | 0.080 |
Why?
| | Marijuana Abuse | 1 | 2014 | 217 | 0.080 |
Why?
| | Speech Perception | 1 | 2012 | 84 | 0.080 |
Why?
| | Parents | 2 | 2012 | 1394 | 0.080 |
Why?
| | Exercise Test | 1 | 2013 | 637 | 0.080 |
Why?
| | Algorithms | 2 | 2019 | 1849 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 665 | 0.080 |
Why?
| | Reference Values | 3 | 2008 | 796 | 0.080 |
Why?
| | Blood Pressure | 1 | 2017 | 1765 | 0.080 |
Why?
| | Facial Expression | 1 | 2010 | 66 | 0.080 |
Why?
| | Pregnancy | 2 | 2020 | 7230 | 0.080 |
Why?
| | Models, Statistical | 1 | 2014 | 669 | 0.070 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 129 | 0.070 |
Why?
| | Colorado | 2 | 2019 | 4595 | 0.070 |
Why?
| | Outpatients | 1 | 2012 | 440 | 0.070 |
Why?
| | Corpus Striatum | 1 | 2010 | 181 | 0.070 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 117 | 0.070 |
Why?
| | Artifacts | 2 | 2007 | 143 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2134 | 0.070 |
Why?
| | Arousal | 1 | 2009 | 158 | 0.070 |
Why?
| | Genotype | 2 | 2010 | 1879 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 57 | 0.070 |
Why?
| | Family | 1 | 2012 | 690 | 0.060 |
Why?
| | Aggression | 1 | 2009 | 171 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2009 | 2070 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2007 | 105 | 0.060 |
Why?
| | Communication Disorders | 1 | 2006 | 14 | 0.060 |
Why?
| | Visual Fields | 2 | 2005 | 120 | 0.060 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 224 | 0.060 |
Why?
| | Auditory Cortex | 1 | 2007 | 47 | 0.060 |
Why?
| | Stereotyped Behavior | 1 | 2006 | 22 | 0.060 |
Why?
| | Postprandial Period | 2 | 2019 | 114 | 0.060 |
Why?
| | Rats | 1 | 2015 | 5586 | 0.060 |
Why?
| | Intelligence | 1 | 2006 | 119 | 0.060 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 15 | 0.060 |
Why?
| | Prospective Studies | 2 | 2017 | 8123 | 0.060 |
Why?
| | Judgment | 1 | 2006 | 59 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 559 | 0.050 |
Why?
| | Bias | 1 | 2026 | 197 | 0.050 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2024 | 3 | 0.050 |
Why?
| | Pain | 1 | 2010 | 790 | 0.050 |
Why?
| | Amygdala | 2 | 2016 | 194 | 0.050 |
Why?
| | Visual Pathways | 1 | 2005 | 61 | 0.050 |
Why?
| | Breakfast | 2 | 2016 | 20 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4580 | 0.050 |
Why?
| | Area Under Curve | 1 | 2005 | 335 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 146 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2024 | 298 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2240 | 0.050 |
Why?
| | Head | 1 | 2004 | 125 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 60 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1242 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2007 | 1135 | 0.040 |
Why?
| | Risk Factors | 2 | 2017 | 10921 | 0.040 |
Why?
| | Movement | 1 | 2004 | 290 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2020 | 17438 | 0.040 |
Why?
| | Insulin Resistance | 2 | 2019 | 1247 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2013 | 94 | 0.040 |
Why?
| | Peptide YY | 1 | 2019 | 28 | 0.040 |
Why?
| | Ghrelin | 1 | 2019 | 42 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 295 | 0.040 |
Why?
| | Age Factors | 1 | 2026 | 3347 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 426 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 150 | 0.030 |
Why?
| | Models, Neurological | 1 | 2019 | 252 | 0.030 |
Why?
| | Lunch | 1 | 2016 | 8 | 0.030 |
Why?
| | Language | 1 | 2019 | 315 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 646 | 0.030 |
Why?
| | Taste Perception | 1 | 2014 | 31 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 152 | 0.020 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.020 |
Why?
| | Mothers | 1 | 2019 | 772 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1327 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2013 | 192 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2012 | 94 | 0.020 |
Why?
| | Sucrose | 1 | 2012 | 113 | 0.020 |
Why?
| | Anisotropy | 1 | 2011 | 77 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3206 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 158 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2008 | 8 | 0.020 |
Why?
| | Temperance | 1 | 2008 | 20 | 0.020 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 53 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 64 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5439 | 0.020 |
Why?
| | Alcohol-Related Disorders | 1 | 2008 | 125 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 132 | 0.020 |
Why?
| | United States | 1 | 2024 | 16136 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2113 | 0.010 |
Why?
| | Chewing Gum | 1 | 2004 | 8 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 612 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2008 | 582 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 42 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2005 | 271 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 340 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 251 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 496 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2488 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 872 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2002 | 42 | 0.010 |
Why?
|
|
Tregellas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|